+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Urinary Tract Infection Drug"

From
From
Urinary Tract Infection Treatment Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Levofloxacin Market Report 2025 - Product Thumbnail Image

Levofloxacin Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Methenamine Hippurate Tablets Market Report 2025 - Product Thumbnail Image

Methenamine Hippurate Tablets Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
US Urinary Tract Infection Therapeutics outlook to 2028 - Product Thumbnail Image

US Urinary Tract Infection Therapeutics outlook to 2028

  • Report
  • August 2023
  • 85 Pages
  • United States
From
Loading Indicator

The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs. The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more